|

Impact of Cannabinoids on Menopause Symptoms

RECRUITINGPhase 2Sponsored by Washington State University
Actively Recruiting
PhasePhase 2
SponsorWashington State University
Started2025-03-03
Est. completion2027-01-12
Eligibility
Age40 Years – 60 Years
SexFEMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06831916

Summary

The purpose of the study is to examine the impact of the hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Eligibility

Age: 40 Years – 60 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* designated female at birth
* 40-60 years of age
* able to give informed consent (no intellectual disability)
* stable pharmacotherapeutic regimen, no change in the past 3 months
* abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use for 3 months
* abstinent for supplements, don't add any supplements (no changes in past 3 months)
* own a smartphone
* have access to Zoom on a secure, stable internet connection
* perimenopausal or menopausal

Exclusion Criteria:

* currently taking anti-depressant, anti-anxiety, and/or antipsychotic medication
* severe depression, neurovegetative symptoms, or current suicidality
* psychosis or family history of psychosis
* pregnant or breastfeeding
* chemotherapy
* hypotension
* drug testing for work or other reasons
* illicit drug use in past 3 months (cannabis not illicit)
* heavy alcohol use (4 drinks more than 4x/week)
* international/air travel planned for more than one week in the next 3 months

Conditions3

AnxietyMenopausePerimenopause

Locations1 site

Washington State University - Pullman Campus
Pullman, Washington, 99163
Carrie Cuttler, Ph.D., Psychology509-592-0151carrie.cuttler@wsu.edu

Browse More Trials

Anxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.